BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36540031)

  • 1. Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.
    Li J; Wen W; Mu Z; Du X; Han X
    J Dermatol; 2023 May; 50(5):622-636. PubMed ID: 36540031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Cutaneous Manifestations of COVID-19: A Systematic Review and Public Health Implications.
    Grover A; Choi F; Wang SP
    WMJ; 2023 Dec; 122(5):349-356. PubMed ID: 38180923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.
    Dondi A; Sperti G; Gori D; Guaraldi F; Montalti M; Parini L; Piraccini BM; Lanari M; Neri I
    Eur J Pediatr; 2022 Oct; 181(10):3577-3593. PubMed ID: 35948654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review.
    Rajan M B; Kumar-M P; Bhardwaj A
    Int J Dermatol; 2020 Nov; 59(11):1358-1370. PubMed ID: 32936462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
    Nyasulu PS; Tamuzi JL
    Int J Dermatol; 2024 Jan; 63(1):10-22. PubMed ID: 37965793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Manifestations of COVID-19: A Systematic Review.
    Singh H; Kaur H; Singh K; Sen CK
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):51-80. PubMed ID: 33035150
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management.
    Masood W; Ahmad S; Khan NA; Shakir A; Rokni GR; Gold MH; Cockerell CJ; Schwartz RA; Goldust M
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.
    Fernández-Lázaro D; Garrosa M
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
    Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
    J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatopathology of COVID-19 infection and vaccination.
    Fernández-Figueras MT
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):114-118. PubMed ID: 36197514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "COVID toes": A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings.
    Rocha KO; Zanuncio VV; Freitas BAC; Lima LM
    Pediatr Dermatol; 2021 Sep; 38(5):1143-1149. PubMed ID: 34515379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
    Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M
    Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.
    Sánchez-García V; Hernández-Quiles R; de-Miguel-Balsa E; Docampo-Simón A; Belinchón-Romero I; Ramos-Rincón JM
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):24-38. PubMed ID: 34545625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous manifestations of COVID-19.
    Wang CJ; Worswick S
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    Nakashima C; Kato M; Otsuka A
    J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Patterns and Morphology of COVID-19 Dermatology.
    Agnihothri R; Fox LP
    Dermatol Clin; 2021 Oct; 39(4):487-503. PubMed ID: 34556240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 skin manifestations: an update.
    Sanchez-Flores X; Huynh T; Huang JT
    Curr Opin Pediatr; 2021 Aug; 33(4):380-386. PubMed ID: 34127574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.
    Askin O; Altunkalem RN; Altinisik DD; Uzuncakmak TK; Tursen U; Kutlubay Z
    Dermatol Ther; 2020 Nov; 33(6):e13896. PubMed ID: 32579756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.